“SPDEF drives pancreatic adenocarcinoma progression via transcriptional upregulation of S100A16 and activation of the PI3K/AKT signaling pathway” (2024) Biomolecules and Biomedicine, 24(5), pp. 1231–1243. doi:10.17305/bb.2024.10346.